{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:57:14Z","timestamp":1793246234053,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Siriraj Research and Development Fund, Faculty of Medicine Siriraj Hospital, Mahidol University","award":["R016133006"],"award-info":[{"award-number":["R016133006"]}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["IRG 5980006"],"award-info":[{"award-number":["IRG 5980006"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Singapore Ministry of Education"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.virusres.2018.07.018","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T12:33:45Z","timestamp":1532522025000},"page":"171-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Drug repurposing of quinine as antiviral against dengue virus infection"],"prefix":"10.1016","volume":"255","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-1629","authenticated-orcid":false,"given":"Shilu","family":"Malakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8585-1888","authenticated-orcid":false,"given":"Liji","family":"Sreelatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanyaporn","family":"Dechtawewat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sansanee","family":"Noisakran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa-thai","family":"Yenchitsomanus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin Jang Hann","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thawornchai","family":"Limjindaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2018.07.018_bib0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1475-2875-10-144","article-title":"Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria","volume":"10","author":"Achan","year":"2011","journal-title":"Malar. J."},{"issue":"8","key":"10.1016\/j.virusres.2018.07.018_bib0010","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.virusres.2018.07.018_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jdermsci.2007.05.009","article-title":"Antiviral effects of quinine sulfate on HSV-1 HaCat cells infected: analysis of the molecular mechanisms involved","volume":"47","author":"Baroni","year":"2007","journal-title":"J. Dermatol. Sci."},{"issue":"11","key":"10.1016\/j.virusres.2018.07.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005194","article-title":"Drivers of inter-individual variation in dengue viral load dynamics","volume":"12","author":"Ben-Shachar","year":"2016","journal-title":"PLoS Comput. Biol."},{"issue":"7446","key":"10.1016\/j.virusres.2018.07.018_bib0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2018.07.018_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2014.03.014","article-title":"Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity","volume":"106","author":"Boonyasuppayakorn","year":"2014","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2018.07.018_bib0035","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2741\/4630","article-title":"Drug repurposing approaches to fight Dengue virus infection and related diseases","volume":"23","author":"Botta","year":"2018","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"6","key":"10.1016\/j.virusres.2018.07.018_bib0040","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/jir.2014.0129","article-title":"Dengue virus control of type I IFN responses: a history of manipulation and control","volume":"35","author":"Castillo Ramirez","year":"2015","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virusres.2018.07.018_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.09.007","article-title":"Antiviral activity of lanatoside C against dengue virus infection","volume":"111","author":"Cheung","year":"2014","journal-title":"Antiviral Res."},{"issue":"18","key":"10.1016\/j.virusres.2018.07.018_bib0050","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1128\/JVI.01006-10","article-title":"Exploiting drug repositioning for discovery of a novel HIV combination therapy","volume":"84","author":"Clouser","year":"2010","journal-title":"J. Virol."},{"issue":"17","key":"10.1016\/j.virusres.2018.07.018_bib0055","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1128\/JVI.74.17.7814-7823.2000","article-title":"Infection of human cells by dengue virus is modulated by different cell types and viral strains","volume":"74","author":"Diamond","year":"2000","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2018.07.018_bib0060","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1128\/JVI.74.11.4957-4966.2000","article-title":"Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons","volume":"74","author":"Diamond","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.07.018_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/282734","article-title":"Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6\/36 cells","volume":"2013","author":"Farias","year":"2013","journal-title":"ScientificWorldJournal"},{"issue":"3","key":"10.1016\/j.virusres.2018.07.018_bib0070","doi-asserted-by":"crossref","first-page":"e967","DOI":"10.1371\/journal.pntd.0000967","article-title":"Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam","volume":"5","author":"Fox","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2018.07.018_bib0075","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jmb.2013.11.023","article-title":"Innate immunity to dengue virus infection and subversion of antiviral responses","volume":"426","author":"Green","year":"2014","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.virusres.2018.07.018_bib0080","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-4632.2005.02769.x","article-title":"Azelaic acid (15% gel) in the treatment of acne rosacea","volume":"46","author":"Gupta","year":"2007","journal-title":"Int. J. Dermatol."},{"issue":"9599","key":"10.1016\/j.virusres.2018.07.018_bib0085","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","volume":"370","author":"Halstead","year":"2007","journal-title":"Dengue. Lancet"},{"issue":"9","key":"10.1016\/j.virusres.2018.07.018_bib0090","doi-asserted-by":"crossref","first-page":"5414","DOI":"10.1128\/JVI.79.9.5414-5420.2005","article-title":"Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression","volume":"79","author":"Jones","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.07.018_bib0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","author":"Kell","year":"2015","journal-title":"Virology 479-480"},{"issue":"3","key":"10.1016\/j.virusres.2018.07.018_bib0100","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cyto.2008.07.009","article-title":"Innate immune response to viral infection","volume":"43","author":"Koyama","year":"2008","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.virusres.2018.07.018_bib0105","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1073\/pnas.1519657113","article-title":"Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses","volume":"113","author":"Li","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.virusres.2018.07.018_bib0110","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-I-like receptors","volume":"34","author":"Loo","year":"2011","journal-title":"Immunity"},{"issue":"suppl_2","key":"10.1016\/j.virusres.2018.07.018_bib0115","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/infdis\/jiw423","article-title":"Current status of dengue therapeutics research and development","volume":"215","author":"Low","year":"2017","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.virusres.2018.07.018_bib0120","doi-asserted-by":"crossref","first-page":"e110631","DOI":"10.1371\/journal.pone.0110631","article-title":"Inhibition of influenza virus replication by targeting broad host cell pathways","volume":"9","author":"Marois","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.virusres.2018.07.018_bib0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00128071-200001020-00009","article-title":"Topical aminolevulinic acid HCl photodynamic therapy","volume":"1","author":"Ormrod","year":"2000","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.virusres.2018.07.018_bib0130","first-page":"S298","article-title":"Hepatic dysfunction in dengue patients with various severity","volume":"1","author":"Pancharoen","year":"2002","journal-title":"J Med Assoc Thai 85 Suppl"},{"key":"10.1016\/j.virusres.2018.07.018_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/bmb\/ldh059","article-title":"The treatment of complicated and severe malaria","volume":"75\u201376","author":"Pasvol","year":"2005","journal-title":"Br. Med. Bull."},{"issue":"2","key":"10.1016\/j.virusres.2018.07.018_bib0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0042-6822(90)90099-D","article-title":"Acidotropic amines inhibit proteolytic processing of flavivirus prM protein","volume":"174","author":"Randolph","year":"1990","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.virusres.2018.07.018_bib0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"7344","key":"10.1016\/j.virusres.2018.07.018_bib0150","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.virusres.2018.07.018_bib0155","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.trstmh.2005.10.007","article-title":"Pathogenesis of liver involvement during dengue viral infections","volume":"100","author":"Seneviratne","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.virusres.2018.07.018_bib0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.virusres.2018.07.018_bib0165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00169980","article-title":"Mitoxantrone in the treatment of acute leukemia","volume":"5","author":"Vorobiof","year":"1987","journal-title":"Invest. New Drugs"},{"issue":"2","key":"10.1016\/j.virusres.2018.07.018_bib0170","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1006\/viro.2002.1704","article-title":"High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis","volume":"305","author":"Wang","year":"2003","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virusres.2018.07.018_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D38WS167FR","article-title":"Quinine sulfate and HSV replication","volume":"9","author":"Wolf","year":"2003","journal-title":"Dermatol. Online J."},{"key":"10.1016\/j.virusres.2018.07.018_bib0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2016.11.010","article-title":"Celastrol inhibits dengue virus replication via up-regulating type I interferon and downstream interferon-stimulated responses","volume":"137","author":"Yu","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2018.07.018_bib0185","doi-asserted-by":"crossref","first-page":"45171","DOI":"10.1038\/srep45171","article-title":"Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218302375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218302375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:05:32Z","timestamp":1759154732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218302375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":37,"alternative-id":["S0168170218302375"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2018.07.018","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug repurposing of quinine as antiviral against dengue virus infection","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2018.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}